Erber Aktiengesellschaft
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
Recorded as renamed to DSM Austria GmbH (2025)
2
Ending by 2030
Mar 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 4, 2027The maintenance fee for Use of Coriobacteriia to promote gut health (US 11,690,881) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Apparatus and method for delivering droplets of fluid onto poultry hatchlings (US 11,751,985) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Jul 7, 2027The maintenance fee for Trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive (US 10,526,585) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process (US 11,910,807) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 1 fee due Sep 3, 2027The maintenance fee for Additive for selenium-containing forage (US 10,575,539) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,101,170 | Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,703,460 | Method for the production of an additive for the enzymatic decomposition of mycotoxins, additive, and use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,586,990 | Enzymes for transforming ergopeptines and method therefor In force · From the USPTO record | In force | From the USPTO record | |
| US 10,076,125 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Medium confidence | In force | Medium confidence | |
| US 10,149,489 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Medium confidence | In force | Medium confidence | |
| US 10,779,556 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Medium confidence | In force | Medium confidence | |
| US 11,324,235 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Medium confidence | In force | Medium confidence | |
| US 11,910,807 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Low confidence | In force | Low confidence | |
| US 11,998,027 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Low confidence | In force | Low confidence | |
| US 11,998,028 | Polypeptide for Hydrolytic Cleavage of Zearalenone And/Or Zearalenone Derivatives, Isolated Polynucleotide Thereof as Well as a Polypeptide Containing an Additive, Use of Same as Well as a Process In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 20: 4 patents in force now held by others · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 1 abandoned · 4 no status recorded